Skip to main content

Table 3 Combinations of prescribed treatments for men and women who survived more than 30 days (n = 4025).

From: Use of evidence-based pharmacotherapy after myocardial infarction in Estonia

Treatment combinations Men (%) Women (%)
BB, No. (%) 176 (7.44) 123 (7.41)
ACE/ARB, No. (%) 170 (7.19) 145 (8.73)
Statins, No. (%) 17 (0.72) 12 (0.72)
BB & ACE/ARB, No. (%) 602 (25.45) 525 (31.63)**
BB & statins, No. (%) 130 (5.50) 49 (2.95)**
ACE/ARB and statins, No. (%) 141 (5.96) 63 (3.80)**
BB & ACE/ARB & statins, No. (%) 999 (42.24) 647 (38.98)
No drugs, No. (%) 130 (5.50) 96 (5.78)
Total, No. (%) 2365 (100.00) 1660 (100.00)
  1. BB, beta-blockers; ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin II receptor blockers.
  2. **P < 0.01 for comparison between men and women with Pearson's χ2 test.